Related Experiment Video
Updated: May 26, 2026

Sample Preparation for Metabolic Profiling using MALDI Mass Spectrometry Imaging
Published on: December 22, 2020
Cylindrospermopsin-induced metabolic reprogramming mapped in rat tissues by MALDI imaging
Antonio Casas-Rodríguez1, Cristina María López2, Angela Peralbo-Molina2
1Area of Toxicology, Faculty of Pharmacy, University of Sevilla, Sevilla, Spain.
Abstract:
Cylindrospermopsin (CYN) is a cyanobacterial toxin with hepatotoxic and nephrotoxic properties; however, its spatial distribution and molecular effects in mammalian tissues remain unclear. In this study, matrix-assisted laser desorption/ionisation mass spectrometry imaging (MALDI-MSI) was employed to assess toxin-induced lipid alterations in the stomach, liver, and kidneys of rats orally exposed to 500 μg CYN/kg body weight and euthanised at 0, 2, 4, 6, and 24 h. Cryosections were analysed under optimised conditions for CYN detection, followed by molecular annotation and lipidomic profiling. Spatially resolved ion images revealed distinct lipid and metabolite distributions and tissue-specific metabolic responses. The transient detection of CYN and its adducts in the stomach during early exposure coincided with increased lysophosphatidylcholine and phosphatidylcholine species, suggesting membrane remodelling. The liver exhibited pronounced lipid remodelling, with elevated phosphatidylglycerols and polyunsaturated phosphatidylcholines and decreased phosphatidylethanolamines and sulfatides, consistent with potential mitochondrial dysfunction and inflammatory involvement. In the kidney, detection of CYN by ultra-high performance liquid chromatography-tandem mass spectrometry and spatial accumulation patterns suggested alterations in xenobiotic transport and detoxification. These findings suggest organ-specific lipidomic responses possibly associated with CYN and highlight the utility of MALDI-MSI for in situ investigation of toxin biodistribution and metabolic effects. They provide novel multi-organ spatial insights into early lipidomic changes induced by CYN and support the identification of potential early molecular biomarkers of exposure.
Insights
Cylindrospermopsin (CYN) toxin causes organ-specific lipid changes in rats. Matrix-assisted laser desorption/ionisation mass spectrometry imaging revealed early metabolic alterations in the stomach, liver, and kidneys following CYN exposure.
Area of Science:
- Toxicology
- Metabolomics
- Mass Spectrometry Imaging
Background:
- Cylindrospermopsin (CYN) is a cyanobacterial toxin known for liver and kidney damage.
- The spatial distribution and molecular effects of CYN in mammalian tissues are not fully understood.
Purpose of the Study:
- To investigate the spatial distribution and molecular effects of CYN in rat tissues.
- To assess CYN-induced lipid alterations in the stomach, liver, and kidneys using MALDI-MSI.
- To identify potential early molecular biomarkers of CYN exposure.
Main Methods:
- Oral exposure of rats to CYN (500 μg/kg).
- Analysis of stomach, liver, and kidney cryosections using matrix-assisted laser desorption/ionisation mass spectrometry imaging (MALDI-MSI).
- Lipidomic profiling and molecular annotation of detected metabolites.
Main Results:
- Spatially resolved ion images showed distinct tissue-specific lipid and metabolite distributions.
- Early CYN exposure in the stomach correlated with increased lysophosphatidylcholine and phosphatidylcholine species.
- The liver exhibited significant lipid remodelling, including elevated phosphatidylglycerols and polyunsaturated phosphatidylcholines, and decreased phosphatidylethanolamines and sulfatides.
- Kidney analysis suggested alterations in xenobiotic transport and detoxification pathways.
Conclusions:
- MALDI-MSI is effective for in situ investigation of toxin biodistribution and metabolic effects.
- CYN exposure induces organ-specific lipidomic responses in mammals.
- The study provides novel multi-organ spatial insights into early lipidomic changes induced by CYN, supporting the identification of potential biomarkers.

